A Midazolam Drug Interaction Study With PF-04171327

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to investigate the effects of multiple doses of PF-04171327 on the blood levels (pharmacokinetics) of midazolam

Key facts

Study ID

NCT00987038

Run by

Pfizer

People needed

12

Starts

2009-09-01

Expected to finish

2009-12-01

Last updated by the study team

2009-12-08

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males and/or females (non-childbearing potential) volunteers.
• Cortisol level within normal reference range of the laboratory.

You may not qualify if…

• History of intolerance or significant adverse effect with glucocorticoid (steroid) therapy.
• History or current positive results for HIV, Hepatitis B or C or active TB or currently undergoing treatment for TB.
• Known history of hypersensitivity, allergy severe drug reaction or unable to tolerate midazolam or other benzodiazepines.

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.